Temporary Epicardial Cardiac Resynchronisation.

Status Completed

Clinical Trial Summary

This trial will investigate the clinical and haemodynamic effects of temporary biventricular pacing after cardiac surgery. Subjects with poor left ventricular systolic function will receive either temporary biventricular pacing or 'standard' post-operative pacing for 48 hours.

The investigators hypothesis that reversal of cardiac dyssynchrony will improve tissue perfusion and cardiac haemodynamics after surgical revascularisation. This will shorten post-operative recovery in cardiac ITU.

Clinical Trial Description

Patients with poor left ventricular (LV) function are at higher risk of complications after cardiac surgery, compared to patients with preserved LV function. The higher complication rates also lead to prolonged Cardiac Intensive Care (CITU) admissions for monitoring and multi-organ support.

The investigators hypothesise that BiV pacing will reverse cardiac dyssynchrony and improve target organ perfusion. This will be significantly reduced the post operative requirement for Level 3 CITU care.

This study will compare 48 hours of temporary biventricular (BiV) pacing to enhance cardiac function against standard post-operative pacing, in patients with poor LV function undergoing cardiac surgery. Temporary biventricular (BiV) pacing will be achieved with the addition of a third pacing electrode attached to the left ventricle. Using a pulmonary arterial catheter the interventricular (VV) delay will be adjusted to yield the maximum cardiac output at constant heart rate- sequential BiV pacing. A pilot study conducted at the University Hospital of Wales (UHW) showed that this approach is likely to be successful.

The primary endpoint of the study will be the mean duration of Level 3 CITU care required by patients after cardiac surgery. Secondary endpoints will include: haemodynamic improvement with BiV pacing; post-operative renal function; atrial fibrillation (AF)/ ventricular arrhythmias; post operative inotropic requirements and changes in biomarkers- NT Pro BNP and Troponin T. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01027299
Study type	Interventional
Source	Cardiff and Vale University Health Board
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	January 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03799133` - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery	N/A
Not yet recruiting	`NCT04538469` - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Terminated	`NCT02205411` - Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation	N/A
Completed	`NCT02524574` - Tomography Positron Emission Assessment of the Impact of Cardiac Rehabilitation on Coronary Endothelial Function in Cardiac Failure	N/A
Active, not recruiting	`NCT03841084` - Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial	Phase 2
Terminated	`NCT02459054` - Syncardia 50cc TAH-t as a Bridge to Transplant	N/A
Terminated	`NCT02859636` - Pronostic Value of Endothelial Dysfunction in Heart Failure	N/A
Completed	`NCT04599816` - Levosimendan Administration in Pulmonary Hypertension	N/A
Recruiting	`NCT05761639` - Physical Exercise and Telephone Follow-up Mediated by Telerehabilitation	N/A
Not yet recruiting	`NCT04696523` - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage	Phase 2
Completed	`NCT03357731` - A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function	Phase 2
Completed	`NCT02331264` - Cardiac Assessment of Patients With Hip Implants	N/A
Terminated	`NCT01921829` - Protocolized Diuretic Strategy in Cardiorenal Failure	Phase 4
Completed	`NCT06197256` - Cardiac Dysfunction in Critically Ill Covid-19 Patients
Recruiting	`NCT03197792` - Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy	N/A
Completed	`NCT03515980` - An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function	Phase 1
Completed	`NCT03212898` - Pharmacist Interventions in Rural Elderly Warfarin Patients	N/A
Completed	`NCT03243604` - cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study
Completed	`NCT06330103` - Efficacy of AI EF Screening by Using Smartphone Application Recorded PLAX View Cardiac Ultrasound Video Clips	N/A
Completed	`NCT02660385` - Insomnia Self-Management in Heart Failure	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.